ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral Total Knee Arthroplasty (TKA)

Study Purpose

ROMTech is focused on transforming the healthcare market by delivering lower extremity rehabilitation systems that are effective, efficient for patient use, cost-effective, and provide better patient outcomes while simultaneously decreasing rehabilitation and overall recovery times.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Male or female ≥18 years of age at screening visit.
  • - Documentation of a definitive diagnosis of osteoarthritis of the knee requiring total knee arthroplasty.
  • - Scheduled or willing to schedule TKA procedure within the timelines consistent with the study enrollment period.
This includes up to a 28-day screening window prior to the scheduled surgery.
  • - Willing to consent to outpatient, home-based physical therapy, CPM, or the ROMTech protocol.
  • - Able to provide written informed consent.
  • - Willing and able to participate in and complete all study assessments, questionnaires, and procedure.

Exclusion Criteria:

  • - Inability to provide informed consent.
  • - Inability to understand and complete study related assessments and procedures.
  • - Other scheduled surgical knee procedures in addition to the TKA.
  • - Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the subject or the quality of the data.
  • - History of musculoskeletal or neurological disorders that limit physical function including but not limited to severe spine OA, contralateral leg issues limiting mobility, and other disorders as identified by the investigator.
- Planned additional knee joint surgery within 3 months of the primary scheduled TKA

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04497129
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

ROM Technologies, INC
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Ryan Nunley, MD
Principal Investigator Affiliation ROM Tech
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Knee Osteoarthritis, Knee Arthritis, Knee Pain Chronic, Knee Disease, Joint Pain, Osteo Arthritis Knee, Osteoarthritis, Knee
Additional Details

The patented technology of the ROMTech PortableConnect can improve the rehabilitation protocol for lower extremities in shorter time periods. The focus of this study is to compare the effectiveness of the ROMTech PortableConncect device only rehabilitation program following total knee arthroplasty to an active comparator group of continuous passive motion with a standard of care combination HHPT and OPPT rehabilitation program. The technology used to develop the ROMTech PortableConnect device has been reported in a pilot study to tend to be highly effective in decreasing the recovery time of patients post TKA, as discussed in the findings from the pilot study with the ROMTech Pro Cycle. The expedited recovery resulting from use of the ROMTech rehabilitation technology is noted to be contributed to the ability of the ROMTech technology to achieve a more rapid range of motion in this patient population.

Arms & Interventions

Arms

Experimental: ROMTech PortableConnect

Rehabilitation Using the ROMTech PortableConnect Device

Active Comparator: Traditional Rehabilitation & Continuous Passive Motion Device

Combination of OPPT and HHPT in conjunction with CPM device usage

Interventions

Device: - ROMTech PortableConnect

ROMTech PortableConnect (ROMTechPC) therapy will be completed four to five times per day for 6 minutes duration for 6 weeks. The intervention will be administered using the portable rehabilitation unit.

Device: - Traditional Rehabilitation and CPM Device

Continuous passive motion (CPM) with standard of care HHPT and OPPT rehabilitation program (CPM with SOC). Therapy with the CPM will be completed daily from day 0 through week 3 for a total of 6 to 8 hours per day. The HHPT and OPPT rehabilitation program will be a 6-week program based on SOC goals.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

OrthoArizona, Gilbert, Arizona

Status

Recruiting

Address

OrthoArizona

Gilbert, Arizona, 85234

Site Contact

Dameon Hahn

[email protected]

203-663-3202

Aventura Orthopaedics, Aventura, Florida

Status

Recruiting

Address

Aventura Orthopaedics

Aventura, Florida, 33180

Site Contact

Kourtney Trainor

[email protected]

203-663-3202

Orthopaedic Associates of West Florida, Clearwater, Florida

Status

Recruiting

Address

Orthopaedic Associates of West Florida

Clearwater, Florida, 33756

Site Contact

Michelle MacMillian

[email protected]

203-663-3202

Coeur d'Alene, Idaho

Status

Recruiting

Address

Institute of Orthopedic Research and Innovation

Coeur d'Alene, Idaho, 83814

Site Contact

Research

[email protected]

203-663-3202

OrthoSouth, Memphis, Tennessee

Status

Recruiting

Address

OrthoSouth

Memphis, Tennessee, 38119

Site Contact

Shane Tripod

[email protected]

203-663-3202